Our data suggest that 44.5% of NF-κB signalling pathway genes were dysregulated in colorectal carcinoma relative to expression in adjacent normal mucosa, when considering all carcinomas as well as MSS and MSI-specific carcinomas and greater levels of FC. The gene discussed is NFKB1; the disease is carcinoma.